HLA-DRA (NM_019111) - major histocompatibility complex, class II, DR alpha
Hla Class Ii Histocompatibility Antigen, Dr Alpha Chain Precursor
Legend
Mutation impacts
Sites
- C-linked
- N-linked
- O-linked
- S-linked
- SARS-CoV-2
Others
If you have any questions or feedback about this protein:
Contact us
Mutations Visualisation
Protein summary
HLA-DRA is one of the HLA class II alpha chain paralogues. This class II molecule is a heterodimer consisting of an alpha and a beta chain, both anchored in the membrane. It plays a central role in the immune system by presenting peptides derived from extracellular proteins. Class II molecules are expressed in antigen presenting cells (APC: B lymphocytes, dendritic cells, macrophages). The alpha chain is approximately 33-35 kDa and its gene contains 5 exons. Exon 1 encodes the leader peptide, exons 2 and 3 encode the two extracellular domains, and exon 4 encodes the transmembrane domain and the cytoplasmic tail. DRA does not have polymorphisms in the peptide binding part and acts as the sole alpha chain for DRB1, DRB3, DRB4 and DRB5. [provided by RefSeq, Jul 2008].
Publication Note:
This RefSeq record includes a subset of the publications that are available for this gene. Please see the Gene record to access additional publications.
Evidence data:
Transcript exon combination :: SRR5189655.110441.1, SRR5189655.82949.1 [ECO:0000332] RNAseq introns :: single sample supports all introns SAMEA1965299, SAMEA1966682 [ECO:0000348]
- Strand
- +
- Chromosome
- 6
- Protein
- 254 residues
- All mutations
- 48
- PTM sites
- 7
- CDS
- 32,407,727 - 32,411,687
- Transcription
- 32,407,618 - 32,412,826
External references
- Entrez
- gene: 3122
-
UniProt